Lysosomal storage disorders : a practical guide /

Awareness of lysomal storage disorders needs to be raised and there is very substantial pharmaceutical interest to do so. The disorders are often viewed as obscurities but in fact they are treatable. Enzyme replacement therapy is available for four of the disorders and will be available for a furthe...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Άλλοι συγγραφείς: Mehta, Atul B., Winchester, Bryan
Μορφή: Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Chichester, West Sussex : Wiley-Blackwell, 2013.
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 05053nam a2200685 4500
001 ocn813987805
003 OCoLC
005 20170124071239.4
006 m o d
007 cr cnu---unuuu
008 121023s2013 enk ob 001 0 eng d
040 |a N$T  |b eng  |e pn  |c N$T  |d E7B  |d YDXCP  |d OCLCQ  |d UIU  |d DG1  |d COO  |d OCLCF  |d NLGGC  |d MHW  |d EBLCP  |d CGU  |d MEAUC  |d DEBSZ  |d CNSPO  |d OCLCQ  |d GrThAP 
019 |a 815389182  |a 872697225 
020 |a 9781118514641  |q (electronic bk.) 
020 |a 1118514645  |q (electronic bk.) 
020 |a 9781118514672  |q (electronic bk.) 
020 |a 111851467X  |q (electronic bk.) 
020 |a 9781283644419  |q (MyiLibrary) 
020 |a 128364441X  |q (MyiLibrary) 
020 |a 9781118514696 
020 |a 1118514696 
020 |z 9780470670873 
020 |z 0470670878 
029 1 |a AU@  |b 000050378592 
029 1 |a DEBBG  |b BV040884973 
029 1 |a DEBSZ  |b 431220263 
029 1 |a GBVCP  |b 79019984X 
029 1 |a NZ1  |b 14836393 
029 1 |a NZ1  |b 15340438 
029 1 |a DEBBG  |b BV043395138 
029 1 |a AU@  |b 000059229202 
035 |a (OCoLC)813987805  |z (OCoLC)815389182  |z (OCoLC)872697225 
050 4 |a RC632.L94 
060 4 |a WD 205 
072 7 |a SCI  |x 017000  |2 bisacsh 
082 0 4 |a 571.6/55  |2 23 
049 |a MAIN 
245 0 0 |a Lysosomal storage disorders :  |b a practical guide /  |c edited by Atul Mehta, Bryan Winchester. 
264 1 |a Chichester, West Sussex :  |b Wiley-Blackwell,  |c 2013. 
300 |a 1 online resource 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
504 |a Includes bibliographical references and index. 
505 0 |a The lysosomal system : physiology and pathology / Matthew C. Micsenyi and Steven U. Walkley -- Clinical aspects and clinical diagnosis / Ed Wraith and Michael Beck -- Laboratory diagnosis of lysosomal storage diseases / Bryan Winchester -- Genetics of lysosomal storage disorders and counseling / John J. Hopwood -- Classification of lysosomal storage diseases / Bryan Winchester -- Gaucher disease / Deborah Elstein and Ari Zimran -- Fabry disease / Atul Mehta and Uma Ramaswami -- The gangliosidoses / Joe T.R. Clarke -- Metachromatic leukodystrophy and globoid cell leukodystrophy / Volkmar Gieselmann, David A. Wenger, and Ingeborg Krägeloh-Mann -- Types A and B Niemannpick disease / Melissa P. Wasserstein, Robert J. Desnick, and Edward H. Schuchman -- Niemannpick disease type C / Marie T. Vanier and Marc C. Patterson -- The mucopolysaccharidoses / Roberto Giugliani -- Pompe disease / Arnold J.J. Reuser and Ans T. van der Ploeg -- Glycoproteinoses / Dag Malm, Hilde Monica F. Riise Stensland and Øivind Nilssen -- Defect in protective protein/cathepsin A : galactosialidosis / Alessandra d'Azzo and Erik J. Bonten -- Multiple enzyme deficiencies -- Defects in transport : mucolipidosis II; mucolipidosis III, and mucolipidosis III / Annick Raas-Rothschild, Sandra Pohl, and Thomas Braulke -- Multiple sulfatase deficiency / Graciana Diez-Roux and Andrea Ballabio -- Lysosomal membrane defects / Michael Schwake and Paul Saftig -- Neuronal ceroid lipofuscinoses / Jonathan D. Cooper and Ruth E. Williams -- Other lysosomal disorders / Bryan Winchester and Timothy M. Cox -- Current treatments / Timothy M. Cox -- Central nervous system aspects, neurodegeneration, and the bloodbrain barrier / David J. Begley and Maurizio Scarpa -- Emerging treatments and future outcomes / T. Andrew Burrow and Gregory A. Grabowski -- Newborn, high risk, and carrier screening for lysosomal storage disorders / Gabor E. Linthorst and Carla E.M. Hollak -- The patient perspective on rare diseases / Alastair Kent, Christine Lavery, and Jeremy Manuel. 
588 0 |a Print version record. 
520 |a Awareness of lysomal storage disorders needs to be raised and there is very substantial pharmaceutical interest to do so. The disorders are often viewed as obscurities but in fact they are treatable. Enzyme replacement therapy is available for four of the disorders and will be available for a further three disorders in the course of the next year. Substrate reduction therapy is licensed for one of them but in the course of the next 12 months it will be licensed for two others and a new form of substrate reduction therapy is being introduced. These diseases present to a very wide range of phy. 
650 0 |a Lysosomal storage diseases. 
650 2 |a Lysosomal Storage Diseases. 
650 2 |a Lysosomes  |x pathology. 
650 4 |a Lysosomal Storage Diseases. 
650 4 |a Lysosomes  |x pathology. 
650 7 |a SCIENCE  |x Life Sciences  |x Cell Biology.  |2 bisacsh 
650 7 |a Lysosomal storage diseases.  |2 fast  |0 (OCoLC)fst01004400 
655 4 |a Electronic books. 
700 1 |a Mehta, Atul B. 
700 1 |a Winchester, Bryan. 
776 0 8 |i Print version:  |t Lysosomal storage disorders.  |d Chichester, West Sussex : Wiley-Blackwell, 2013  |z 9780470670873  |w (DLC) 2012017385  |w (OCoLC)793073834 
856 4 0 |u https://doi.org/10.1002/9781118514672  |z Full Text via HEAL-Link 
994 |a 92  |b DG1